Evidence of pathogenicity for the leaky splice variant c.1066-6T>Gin ATM

Simone Schröder1, Britta Wieland2, Andreas Ohlenbusch1

  • 1Interdisciplinary Pediatric Center for Children with Developmental Disabilities and Severe Chronic Disorders, University Medical Center Göttingen, Göttingen, Germany.

Insights

Mild ataxia-telangiectasia (variant A-T) is linked to ATM variants with residual kinase function. This study confirms the pathogenicity of the leaky ATM splice site variant c.1066-6T>G in variant A-T patients.

Area of Science:

  • Genetics and Molecular Biology
  • Neuroscience

Background:

  • Mild clinical phenotypes of ataxia-telangiectasia (variant A-T) are associated with biallelic ATM variants.
  • These variants result in residual function of the ATM kinase, with identified mutations including missense or leaky splice site alterations.

Observation:

  • Whole-exome sequencing identified compound heterozygous ATM variants (c.1066-6T>G and c.2250G>A) in a patient diagnosed with congenital ocular motor apraxia type Cogan.
  • Reappraisal of the patient's phenotype aligned with variant A-T.
  • Functional analyses revealed reduced ATM protein expression and residual ATM kinase activity.

Findings:

  • The study provides evidence for the pathogenicity of the leaky ATM splice site variant c.1066-6T>G.
  • This variant, in conjunction with c.2250G>A, results in a mild clinical phenotype consistent with variant A-T.

Implications:

  • Confirms the role of the c.1066-6T>G splice site variant in the etiology of variant ataxia-telangiectasia.
  • Highlights the importance of functional analyses in determining the pathogenicity of splice site variants.
  • Contributes to a better understanding of genotype-phenotype correlations in ATM-related disorders.